HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dayan Goodenowe Selected Research

phosphatidal ethanolamines

3/2020Altered ethanolamine plasmalogen and phosphatidylethanolamine levels in blood plasma of patients with bipolar disorder.
6/2015Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dayan Goodenowe Research Topics

Disease

2Parkinson Disease (Parkinson's Disease)
01/2016 - 06/2015
1Bipolar Disorder (Manic Depressive Psychosis)
03/2020
1Dyskinesias (Dyskinesia)
06/2015

Drug/Important Bio-Agent (IBA)

2phosphatidal ethanolaminesIBA
03/2020 - 06/2015
2PlasmalogensIBA
01/2016 - 06/2015
1phosphatidylethanolamineIBA
03/2020
1Docosahexaenoic AcidsIBA
06/2015
1Pharmaceutical PreparationsIBA
06/2015
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2015
1Levodopa (L Dopa)FDA LinkGeneric
06/2015